Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011;50(5):600–13.
Cunliffe-Beamer TLaL, E.P. . In The UFAW Handbook on the Care and Management of Laboratory Animals. Longman Scientific and Technical, Essex. 1987;6th:275–308.
Eldridge SF, McDonald, K.E., Renne, R.A. and Lewis, T.R. Lab Anim 11. 1982;11:50–54.
Simmons MLaB, J.O. . In The Laboratory Mouse (ed. A. Hollaender). Prentice-Hall Inc, Englewood Cliffs. 1970:127–129.
Morton DB, Jennings M, Buckwell A, Ewbank R, Godfrey C, Holgate B, Inglis I, James R, Page C, Sharman I, Verschoyle R, Westall L, Wilson AB, Joint Working Group on R. Refining procedures for the administration of substances. Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation/Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Prevention of Cruelty to Animals/Universities Federation for Animal Welfare. Lab Anim. 2001;35(1):1–41.
Wegner G. Chirurgische Bemerkungen uber die peritonealhohle, mit besonderer Berrucksichtigung der Ovariotomie. Langenbecks Arch Chir. 1877;20(51):145.
Hanbidge AE, Lynch D, Wilson SR. US of the peritoneum. Radiographics. 2003;23(3):663–84 discussion 684-665.
Hartveit F, Thunold S. Peritoneal fluid volume and the oestrus cycle in mice. Nature. 1966;210(5041):1123–5.
Aune S. Transperitoneal exchange. IV. The effect of transperitoneal fluid transport on the transfer of solutes. Scand J Gastroenterol. 1970;5(4):241–52.
Blackburn SC, Stanton MP. Anatomy and physiology of the peritoneum. Semin Pediatr Surg. 2014;23(6):326–30.
Michailova K, Wassilev W, Wedel T. Scanning and transmission electron microscopic study of visceral and parietal peritoneal regions in the rat. Ann Anat. 1999;181(3):253–60.
Albertine KH, Wiener-Kronish JP, Roos PJ, Staub NC. Structure, blood supply, and lymphatic vessels of the sheep's visceral pleura. Am J Anat. 1982;165(3):277–94.
Gotloib L, Digenis GE, Rabinovich S, Medline A, Oreopoulos DG. Ultrastructure of normal rabbit mesentery. Nephron. 1983;34(4):248–55.
Mutsaers SE, Whitaker D, Papadimitriou JM. Changes in the concentration of microvilli on the free surface of healing mesothelium are associated with alterations in surface membrane charge. J Pathol. 1996;180(3):333–9.
Whitaker D, Papadimitriou J. Mesothelial healing: morphological and kinetic investigations. J Pathol. 1985;145(2):159–75.
Shimotsuma M, Shields JW, Simpson-Morgan MW, Sakuyama A, Shirasu M, Hagiwara A, et al. Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology. 1993;26(2):90–101.
Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 1990;37(6):1563–70.
Howard JM, Singh LM. Peritoneal fluid Ph after perforation of peptic ulcers: the myth of "acid-peritonitis". Arch Surg. 1963;87:483–4.
Moretz WH, Erickson WG. Neutralization of hydrochloric acid in the peritoneal cavity. AMA Arch Surg. 1957;75(5):834–7.
Aguirre AR, Abensur H. Physiology of fluid and solute transport across the peritoneal membrane. J Bras Nefrol. 2014;36(1):74–9.
Solass W, Horvath P, Struller F, Konigsrainer I, Beckert S, Konigsrainer A, et al. Functional vascular anatomy of the peritoneum in health and disease. Pleura Peritoneum. 2016;1(3):145–58.
Michailova KN, Usunoff KG. Serosal membranes (pleura, pericardium, peritoneum). Normal structure, development and experimental pathology. Adv Anat Embryol Cell Biol. 2006;183:i-vii, 1–144, back cover.
Gotloib L, Shustak A, Bar-Sella P, Eiali V. Heterogeneous density and ultrastructure of rabbit's peritoneal microvasculature. Int J Artif Organs. 1984;7(3):123–5.
Aune S. Transperitoneal exchange. II. Peritoneal blood flow estimated by hydrogen gas clearance. Scand J Gastroenterol. 1970;5(2):99–104.
Flessner MF. Transport of water solube solutes between the peritoneal cavity and the plasma in the rat [PhD Thesis]. Department of Chemical Engineering, University of Michigan, Ann Arbor. 1981.
Grzegorzewska AE, Moore HL, Nolph KD, Chen TW. Ultrafiltration and effective peritoneal blood flow during peritoneal dialysis in the rat. Kidney Int. 1991;39(4):608–17.
Rippe B, Rosengren BI, Venturoli D. The peritoneal microcirculation in peritoneal dialysis. Microcirculation. 2001;8(5):303–20.
Granger DN, Ulrich M, Perry MA, Kvietys PR. Peritoneal dialysis solutions and feline splanchnic blood flow. Clin Exp Pharmacol Physiol. 1984;11(5):473–81.
Lukas G, Brindle SD, Greengard P. The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther. 1971;178(3):562–4.
Granger HJ. Role of the interstitial matrix and lymphatic pump in regulation of transcapillary fluid balance. Microvasc Res. 1979;18(2):209–16.
Fraser PA, Smaje LH, Verrinder A. Microvascular pressures and filtration coefficients in the cat mesentery. J Physiol. 1978;283:439–56.
Olin T, Saldeen T. The lymphatic pathways from the peritoneal cavity: A Lymphangiographic study in the Rat. Cancer Res. 1964;24:1700–11.
Esperanca MJCDL. Peritoneal dialysis efficiency in relation to body weight. J Pediatr Surg. 1966;1(2):162–9.
Kuzlan M, Pawlaczyk K, Wieczorowska-Tobis K, Korybalska K, Breborowicz A, Oreopoulos DG. Peritoneal surface area and its permeability in rats. Perit Dial Int. 1997;17(3):295–300.
Zink J, Greenway CV. Control of ascites absorption in anesthetized cats: effects of intraperitoneal pressure, protein, and furosemide diuresis. Gastroenterology. 1977;73(5):1119–24.
Jacquet P, Vidal-Jove J, Zhu B, Sugarbaker P. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. Acta Chir Belg. 1994;94(4):191–7.
Sugarbaker PH. Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma. Eur J Surg Suppl. 1991;561:75–82.
Fedorko ME, Hirsch JG, Fried B. Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. II. Kinetic features and metabolic requirements. Exp Cell Res. 1971;69(2):313–23.
Williams R, White H. The greater omentum: its applicability to cancer surgery and cancer therapy. Curr Probl Surg. 1986;23(11):789–865.
Surbone A, Myers CE. Principles and practice of intraperitoneal therapy. Antibiot Chemother (1971). 1988;40:14–25.
Flessner MF, Dedrick RL, Schultz JS. Exchange of macromolecules between peritoneal cavity and plasma. Am J Phys. 1985;248(1 Pt 2):H15–25.
Mactier RA, Khanna R. Absorption of fluid and solutes from the peritoneal cavity. Theoretic and therapeutic implications and applications. ASAIO Trans. 1989;35(2):122–31.
Gross ML, Somani P, Ribner BS, Raeader R, Freimer EH, Higgins JT Jr. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1983;34(5):673–80.
Canal P, Plusquellec Y, Chatelut E, Bugat R, De Biasi J, Houin G. A pharmacokinetic model for intraperitoneal administration of drugs: application to teniposide in humans. J Pharm Sci. 1989;78(5):389–92.
Flessner MF. Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol. 1991;2(2):122–35.
Chambers R, Zwiefach BW. Functional activity of the blood capillary bed, with special reference to visceral tissue. Ann N Y Acad Sci. 1946;46:683–94.
Guyton AV, Hall JE. Chapter 14: Overview of the circulation; medical physics of pressure, flow, and resistance. In: Guyton AV, Hall JE, editors. Textbook of medical physiology. 11th ed. Philadelphia: Elsevier; 2006.
Karnovsky MJ. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol. 1967;35(1):213–36.
Bruns RR, Palade GE. Studies on blood capillaries. II. Transport of ferritin molecules across the wall of muscle capillaries. J Cell Biol. 1968;37(2):277–99.
Di Paolo N, Sacchi G. Anatomy and physiology of the peritoneal membrane. Contrib Nephrol. 1990;84:10–26.
Bajaj G, Yeo Y. Drug delivery Systems for Intraperitoneal Therapy. Pharm Res-Dordr. 2010;27(5):735–8.
Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Investig. 1987;17(1):43–52.
Lockhart RD, Hamilton, G. F. and Fyfe, F. W. Anatomy of the Human Body. J B Lippincott Company, Philadelphia. 1960.
Romanes GJ. Cunningham’s textbook of anatomy. London: Oxford University Press; 1964.
Torres IJ, Litterst CL, Guarino AM. Transport of model compounds across the peritoneal membrane in the rat. Pharmacology. 1978;17(6):330–40.
Flessner MF, Parker RJ, Sieber SM. Peritoneal lymphatic uptake of fibrinogen and erythrocytes in the rat. Am J Phys. 1983;244(1):H89–96.
Regoeczi E, Zaimi O, Chindemi PA, Charlwood PA. Absorption of plasma proteins from peritoneal cavity of normal rats. Am J Phys. 1989;256(4 Pt 1):E447–52.
Courtice FC, Steinbeck AW. The rate of absorption of heparinized plasma and of 0.9 p.c. NaCl from the peritoneal cavity of the rabbit and Guinea-pig. Aust J Exp Biol Med Sci. 1950;28(2):171–82.
Courtice FC, Steinbeck AW. The lymphatic drainage of plasma from the peritoneal cavity of the cat. Aust J Exp Biol Med Sci. 1950;28(2):161–9.
Courtice FC, Simmonds WJ. Physiological significance of lymph drainage of the serous cavities and lungs. Physiol Rev. 1954;34(3):419–48.
Raybuck HE, Allen L, Harms WS. Absorption of serum from the peritoneal cavity. Am J Phys. 1960;199:1021–4.
Allen L. Vogt E. A mechanism of lymphatic absorption from serous cavity Am J Physiol. 1937;119:776–82.
Abernethy NJ, Chin W, Hay JB, Rodela H, Oreopoulos D, Johnston MG. Lymphatic drainage of the peritoneal cavity in sheep. Am J Phys. 1991;260(3 Pt 2):F353–8.
Durk MR, Deshmukh G, Valle N, Ding X, Liederer BM, Liu X. Use of subcutaneous and Intraperitoneal administration methods to facilitate cassette dosing in microdialysis studies in rats. Drug Metab Dispos. 2018;46(7):964–9.
Deshmukh G, Sun K, Liederer BM, Ding X, Liu X. Use of cassette dosing to enhance the throughput of rat brain microdialysis studies. Drug Metab Dispos. 2015;43(7):1123–8.
Liu X, Van Natta K, Yeo H, Vilenski O, Weller PE, Worboys PD, et al. Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos. 2009;37(4):787–93.
Shimada T, Nomura M, Yokogawa K, Endo Y, Sasaki T, Miyamoto K, et al. Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice. J Pharm Pharmacol. 2005;57(2):177–81.
Hu K, Cao S, Hu F, Feng J. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomedicine. 2012;7:3537–45.
Nemes KB, Abermann M, Bojti E, Grezal G, Al-Behaisi S, Klebovich I. Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat. J Pharm Pharmacol. 2000;52(1):47–51.
Kim C, Kim IH, Kim SI, Kim YS, Kang SH, Moon SH, et al. Comparison of the Intraperitoneal, Retroorbital and per Oral routes for F-18 FDG administration as effective alternatives to intravenous Administration in Mouse Tumor Models Using Small Animal PET/CT studies. Nucl Med Mol Imaging. 2011;45(3):169–76.
Matzneller P, Kussmann M, Eberl S, Maier-Salamon A, Jager W, Bauer M, et al. Pharmacokinetics of the P-gp inhibitor Tariquidar in rats after intravenous, Oral, and Intraperitoneal administration. Eur J Drug Metab Pharmacokinet. 2018;43(5):599–606.
Rozewski DM, Herman SE, Towns WH 2nd, Mahoney E, Stefanovski MR, Shin JD, et al. Pharmacokinetics and tissue disposition of lenalidomide in mice. AAPS J. 2012;14(4):872–82.
Abu-Hijleh MF, Habbal OA, Moqattash ST. The role of the diaphragm in lymphatic absorption from the peritoneal cavity. J Anat. 1995;186(Pt 3):453–67.
Sane R, Mittapalli RK, Elmquist WF. Development and evaluation of a novel microemulsion formulation of elacridar to improve its bioavailability. J Pharm Sci. 2013;102(4):1343–54.
Chang R, Al Maghribi A, Vanderpoel V, Vasilevko V, Cribbs DH, Boado R, et al. Brain penetrating Bifunctional erythropoietin-transferrin receptor antibody fusion protein for Alzheimer's disease. Mol Pharm. 2018;15(11):4963–73.
Lee B, Clarke D, Al Ahmad A, Kahle M, Parham C, Auckland L, et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest. 2011;121(8):3005–23.
Zhang B, Dai J, Wang H, Wei H, Zhao J, Guo Y, et al. Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis. Biochem Biophys Res Commun. 2014;452(3):795–800.
Wangler NJ, Jayaraman S, Zhu R, Mechref Y, Abbruscato TJ, Bickel U, et al. Preparation and preliminary characterization of recombinant neurolysin for in vivo studies. J Biotechnol. 2016;234:105–15.
Sumbria RK, Zhou QH, Hui EK, Lu JZ, Boado RJ, Pardridge WM. Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice. Mol Pharm. 2013;10(4):1425–31.
Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res. 2007;61(6):671–5.
Veronese FM, Caliceti P, Pastorino A, Schiavon O, Sartore L, Banci L, et al. Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase. J Control Release. 1989;10(1):145–54.
Parkes D, Jodka C, Smith P, Nayak S, Rinehart L, Gingerich R, et al. Pharmacokinetic actions of Exendin-4 in the Rat: comparison with glucagon-like Peptide-1. Drug Dev Res. 2001;53:260–7.
Jacobs CA, Beckmann MP, Mohler K, Maliszewski CR, Fanslow WC, Lynch DH. Pharmacokinetic parameters and biodistribution of soluble cytokine receptors. Int Rev Exp Pathol. 1993;34 Pt B:123–135.
Barrett JS, Wagner JG, Fisher SJ, Wahl RL. Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat. Cancer Res. 1991;51(13):3434–44.
Koizumi K, DeNardo GL, DeNardo SJ, Hays MT, Hines HH, Scheibe PO, et al. Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancer. J Nucl Med. 1986;27(8):1243–54.
Griffiths K, Binder U, McDowell W, Tommasi R, Frigerio M, Darby WG, et al. Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4. MAbs. 2019;11(7):1331–40.
Fam CM, Eisenberg SP, Carlson SJ, Chlipala EA, Cox GN, Rosendahl MS. PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice. J Interf Cytokine Res. 2014;34(10):759–68.
Goldenberg DM, Rossi EA, Stein R, Cardillo TM, Czuczman MS, Hernandez-Ilizaliturri FJ, et al. Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody. Blood. 2009;113(5):1062–70.
Shi Q, Kuether EL, Schroeder JA, Fahs SA, Montgomery RR. Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice. Haemophilia. 2012;18(4):639–46.
Gerrard AJ, Austen DE, Brownlee GG. Subcutaneous injection of factor IX for the treatment of haemophilia B. Br J Haematol. 1992;81(4):610–3.
Claassen V. Chap: 5 - Intraperitoneal drug administration; 1994.
Cardenas PA, Kratz JM, Hernandez A, Costa GM, Ospina LF, Baena Y, Simoes CMO, Jimenez-Kairuz A, Aragon M. In vitro intestinal permeability studies, pharmacokinetics and tissue distribution of 6-methylcoumarin after oral and intraperitoneal administration in Wistar rats. Braz J Pharm Sci. 2017;53(1).
Sane R, Agarwal S, Elmquist WF. Brain distribution and bioavailability of elacridar after different routes of administration in the mouse. Drug Metab Dispos. 2012;40(8):1612–9.
Sofia RD, Kubena RK, Barry H 3rd. Comparison of four vehicles for intraperitoneal administration of -tetrahydrocannabinol. J Pharm Pharmacol. 1971;23(11):889–91.
Sofia RD, Kubena RK, Barry H 3rd. Comparison among four vehicles and four routes for administering δ9-tetrahydrocannabinol. J Pharm Pharmacol. 1974;63(6):939–41.
Ritschel WA, Siegel EG, Ring PE. Biopharmaceutical factors influencing LD50. I Viscosity Arzneimittelforschung. 1974;24(6):907–10.
Sigfridsson K, Lundqvist A, Strimfors M. Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats. Drug Dev Ind Pharm. 2013;39(11):1832–9.
Sigfridsson K, Lundqvist AJ, Strimfors M. Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development. Drug Dev Ind Pharm. 2011;37(3):243–51.
Sigfridsson K, Lundqvist A, Strimfors M. Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats. Drug Dev Ind Pharm. 2014;40(4):511–8.
Dimer FA, Pigatto MC, Boque CA, Pase CS, Roversi K, Pohlmann AR, et al. Nanoencapsulation improves relative bioavailability and antipsychotic effect of olanzapine in rats. J Biomed Nanotechnol. 2015;11(8):1482–93.
Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability. Biomed Pharmacother. 2018;106:1461–8.
Ragelle H, Crauste-Manciet S, Seguin J, Brossard D, Scherman D, Arnaud P, et al. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. Int J Pharm. 2012;427(2):452–9.
Ye M, Wysocki J, Gonzalez-Pacheco FR, Salem M, Evora K, Garcia-Halpin L, et al. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension. 2012;60(3):730–40.
Gotloib L, Wajsbrot V, Shostak A. A short review of experimental peritoneal sclerosis: from mice to men. Int J Artif Organs. 2005;28(2):97–104.
Micossi P, Cristallo M, Librenti MC, Petrella G, Galimberti G, Melandri M, et al. Free-insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administration. Diabetes Care. 1986;9(6):575–8.
Black MC. Routes of administration for chemical agents. The laboratory fish London (UK): Academic Press. 2000.
Lewis REK, A. L.; Bell R. E. Error of intraperitoneal injections in rats. Lab Anim Care. 1966;16:505–9.
Bredberg E, Lennernas H, Paalzow L. Pharmacokinetics of levodopa and carbidopa in rats following different routes of administration. Pharm Res. 1994;11(4):549–55.
Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244(1):106–12.
Bendavid Y, Leblond FA, Dube P. A study of the effect of temperature on the pharmacokinetic profile of raltitrexed administered by intraperitoneal route in the rat. Med Sci Monit. 2005;11(1):BR1–5.
Jacquet P, Averbach A, Stuart OA, Chang D, Sugarbaker PH. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol. 1998;41(2):147–54.
Sharp PELR, M. C. The laboratory rat. Boca Raton (FL): CRC Press LLC; 1997.
Pekow CB, V. Common nonsurgical techniques and procedures. Handbook of laboratory animal science: Boca Raton (FL): CRC Press. 2003;2(2nd ed):351–391.
Woodard G. In methods of animal experimentation. Academic Press, New York. 1965;1:343–59.
De Marco TJ, Levine RR. Role of the lymphatics in the intestinal absorption and distribution of drugs. J Pharmacol Exp Ther. 1969;169(1):142–51.
Davis JN, Courtney CL, Superak H, Taylor DK. Behavioral, clinical and pathological effects of multiple daily intraperitoneal injections on female mice. Lab Anim (NY). 2014;43(4):131–9.
Gad SC, Spainhour CB, Shoemake C, Pallman DR, Stricker-Krongrad A, Downing PA, et al. Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility. Int J Toxicol. 2016;35(2):95–178.